We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+14.04%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.77B
AUM Growth
+$478M
Cap. Flow
+$459M
Cap. Flow %
25.84%
Top 10 Hldgs %
26.92%
Holding
375
New
143
Increased
47
Reduced
48
Closed
115

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.88%
2 Communication Services 13.06%
3 Technology 7.1%
4 Industrials 6.46%
5 Healthcare 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
151
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.68M 0.15%
52,000
-52,000
-50% -$2.25M
EYE icon
152
CALL
National Vision
EYE
$1.76B
$2.67M 0.15%
+85,000
New +$2.67M
INFY icon
153
PUT
Infosys
INFY
$51B
$2.63M 0.15%
+240,500
New +$2.55M
HCCHU
154
DELISTED
HL Acquisitions Corp. Unit
HCCHU
$2.6M 0.15%
250,000
ALK icon
155
Alaska Air
ALK
$5.11B
$2.31M 0.13%
+41,192
New +$2.52M
KDMN
156
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.29M 0.13%
869,400
+149,400
+21% +$377K
QIWI
157
DELISTED
QIWI PLC
QIWI
$2.26M 0.13%
157,280
-157,289
-50% -$2.3M
HUN icon
158
CALL
Huntsman Corp
HUN
$2.1B
$2.25M 0.13%
+100,000
New +$2.25M
CRON
159
PUT
Cronos Group
CRON
$1.07B
$2.21M 0.12%
+120,000
New +$2.25M
CTRC
160
DELISTED
Centric Brands Inc. Common Stock
CTRC
$2.16M 0.12%
479,272
-372,756
-44% -$1.45M
OLED icon
161
CALL
Universal Display
OLED
$3.75B
$2.14M 0.12%
+14,000
New +$1.73M
NTR icon
162
PUT
Nutrien
NTR
$33.9B
$2.11M 0.12%
+40,000
New +$2.08M
NAV
163
DELISTED
Navistar International
NAV
$2.06M 0.12%
63,711
+8,757
+16% +$291K
CBAY
164
DELISTED
Cymabay Therapeutics
CBAY
$2.04M 0.11%
+153,298
New +$1.63M
EIGI
165
CALL
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$2.03M 0.11%
+280,000
New +$2.04M
CNR
166
CALL
DELISTED
Cornerstone Building Brands, Inc.
CNR
$1.91M 0.11%
+310,000
New +$2.27M
FENG
167
Phoenix New Media
FENG
$17.5M
$1.86M 0.1%
73,682
-9,651
-12% -$220K
AXSM icon
168
CALL
Axsome Therapeutics
AXSM
$11.7B
$1.85M 0.1%
+130,000
New +$1.21M
NTR icon
169
CALL
Nutrien
NTR
$33.9B
$1.85M 0.1%
35,000
+15,000
+75% +$781K
ZD icon
170
Ziff Davis
ZD
$2B
$1.85M 0.1%
+24,524
New +$1.69M
SREV
171
DELISTED
ServiceSource International, Inc.
SREV
$1.83M 0.1%
1,988,245
+1,048,245
+112% +$1.1M
FLWS icon
172
CALL
1-800-Flowers.com
FLWS
$252M
$1.82M 0.1%
100,000
-162,500
-62% -$2.62M
GBT
173
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.79M 0.1%
33,789
-55
-0.2% -$2.7K
CSCI
174
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$1.74M 0.1%
3,740
-6,235
-63% -$2.42M
WMB icon
175
Williams Companies
WMB
$85.8B
$1.65M 0.09%
+57,286
New +$1.54M

Similar funds

J. Goldman & Co's Q1 2019 Portfolio in Review

As of Q1 2019, J. Goldman & Co held 375 positions worth $1.77B, up 37% from $1.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

J. Goldman & Co deployed $459M of net new capital in Q1 2019, opening 143 new positions and adding to 47 existing holdings. Its largest new stake was Vonage Holdings Corporation: 3,722,294 shares worth $37.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Collegium Pharmaceutical, an estimated $13.3M trimmed.

  • J. Goldman & Co's largest Q1 2019 buy was Vonage Holdings Corporation: 3,722,294 shares worth $37.4M.
  • J. Goldman & Co added most to Walt Disney in Q1 2019, an estimated $84.2M increase.
  • J. Goldman & Co's biggest Q1 2019 reduction was Collegium Pharmaceutical, cutting an estimated $13.3M.
  • J. Goldman & Co fully exited Ralph Lauren in Q1 2019, selling an estimated $37.2M.
  • J. Goldman & Co's ten largest holdings make up 27% of its $1.77B portfolio in Q1 2019.
  • J. Goldman & Co opened 143 new positions and closed 115 in Q1 2019.
  • J. Goldman & Co's portfolio value rose 37% quarter-over-quarter to $1.77B.

Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.